CN101433357B - 一种含有叶黄素微胶囊的功能性饮料 - Google Patents
一种含有叶黄素微胶囊的功能性饮料 Download PDFInfo
- Publication number
- CN101433357B CN101433357B CN2008101375625A CN200810137562A CN101433357B CN 101433357 B CN101433357 B CN 101433357B CN 2008101375625 A CN2008101375625 A CN 2008101375625A CN 200810137562 A CN200810137562 A CN 200810137562A CN 101433357 B CN101433357 B CN 101433357B
- Authority
- CN
- China
- Prior art keywords
- human body
- functional beverage
- cobastab
- vitamin
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 14
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 8
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 title claims description 32
- 229960005375 lutein Drugs 0.000 title claims description 31
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims description 31
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 title claims description 31
- 235000008210 xanthophylls Nutrition 0.000 title claims description 12
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 18
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 18
- 241001330002 Bambuseae Species 0.000 claims abstract description 18
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 18
- 239000011425 bamboo Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims abstract 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 22
- 235000012680 lutein Nutrition 0.000 claims description 19
- 239000001656 lutein Substances 0.000 claims description 19
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 15
- 229960003080 taurine Drugs 0.000 claims description 11
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 10
- 239000004472 Lysine Substances 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000005715 Fructose Substances 0.000 claims description 8
- 229930091371 Fructose Natural products 0.000 claims description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 8
- 240000003915 Lophatherum gracile Species 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 2
- 238000005538 encapsulation Methods 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 abstract description 9
- 229930003231 vitamin Natural products 0.000 abstract description 9
- 235000013343 vitamin Nutrition 0.000 abstract description 9
- 229940088594 vitamin Drugs 0.000 abstract description 9
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 9
- 150000001413 amino acids Chemical class 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 5
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 208000002177 Cataract Diseases 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 208000001491 myopia Diseases 0.000 abstract description 3
- 230000004379 myopia Effects 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 abstract 4
- 206010064930 age-related macular degeneration Diseases 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000000366 juvenile effect Effects 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
- 235000021049 nutrient content Nutrition 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- -1 cumarin lactone Chemical class 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 229930003944 flavone Natural products 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CCSQMIOAYMMBOJ-QQGJMDNJSA-N OC1(CC(C)(C)C(=C(C1)C)\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1C(C)=CCCC1(C)C)O Chemical compound OC1(CC(C)(C)C(=C(C1)C)\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1C(C)=CCCC1(C)C)O CCSQMIOAYMMBOJ-QQGJMDNJSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N keto-D-fructose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000030097 organ senescence Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Abstract
本发明属于一种含有叶黄素微胶囊的功能性饮料，由叶黄素微胶囊、竹叶提取物、氨基酸及维生素为主要原料，本产品各营养成分相互配合，协同作用，能够促进人体新陈代谢，吸收与分解糖分，迅速补充大量的能量物质，具有预防和改善各种眼部不适的疾病，补充人体所需的维生素、氨基酸，补充体力、抗疲劳的卓越功效，是使用现代先进生产工艺制成的一种预防心脑血管疾病、提高人体免疫力、对恶性肿瘤、青少年性近视、年龄相关性白内障、年龄相关性黄斑变性人群的功能性饮料。
Description
(一)技术领域
本发明涉及一种含有叶黄素微胶囊的功能性饮料。
(二)背景技术
叶黄素(3，3-二羟基-α-胡萝卜素)又名“植物黄体素”，是类胡萝卜素中的一种，是植物中脂溶性色素，在自然界中与玉米黄素(Zeaxanthin)共同存在。叶黄素与玉米黄素是构成玉米、蔬菜、水果、花卉等植物色素的主要组分，也是构成人眼视网膜黄斑区域的主要色素。
1995年美国食品与药物管理局(FDA)批准叶黄素作为食品补充剂用于食品、饮料。将一定量的叶黄素加入到食品中，可防止人体因器官衰老引起的心血管硬化、冠心病和肿瘤疾病等一系列疾病，还可预防细胞衰老和肌体(器官)衰老。
淡竹叶在我国具有悠久的食用和药用历史，是中医著名的清热解毒药，也是我国第三批(1998年)颁布的既是食品又是药品的天然植物。淡竹叶提取浓缩液含有大量的黄酮、酚酸、恩醌类化合物、生物活性多糖、香豆素内酯、特种氨基酸、芳香成分和锰、锌、硒等微量元素。竹叶中所含的功能因子主要是黄酮糖苷和香豆素类内酯，大量的科学研究和实验证明：竹叶黄酮具有优良的抗自由基、抗氧化和抗衰老活性，能显著增强人体的免疫机能，调节脂质代谢，保护心脑血管，抗疲劳、抗菌、抗病毒，护肤、美白，且不含任何有害成分和抗营养因子，是一种十分理想的天然生物黄酮新资源。
本品营养成分中叶黄素和竹叶提取物都是优良的抗氧化剂，可以清除人体内的自由基。自由基(FREE RADICALS)指带有未配对电子的粒子，因为带有单数电子，所以极不稳定，很容易和周围的分子、体内的细胞组织发生化学反应，使稳定分子变成自由基，使细胞组织失去功能而破坏。也会和细胞内的DNA发生反应，破坏DNA，造成基因突变而形成免疫系统的缺陷，加速老化并增加致癌机率。
通常我们体内有对抗氧自由基的抗氧化酶素，及超氧化物歧化酶(SOD)、胱甘过氧化酶(GSH-Px)及过氧化氢酶(Catalase)和从食物中得来的维生素E、维生素C、β-胡萝卜素及硒等抗氧化物构成的抗氧化系统，可以和氧自由基保持一个平衡的状态。然而这种平衡是很脆弱的，只要氧自由基一旦大量产生或抗氧化物的量不足时，就无法完全消除氧自由基。由于叶黄素优异的抗氧化特性，在眼睛中，叶黄素充当了和氧自由基保持平衡状态的主要角色。每天摄入高量的叶黄素，不但可以补充眼睛的营养，让眼睛免受自由基的损害，还可以保证整个身体内的氧化—抗氧化系统保持平衡。
根据在国家知识产权局专利检索的结果，专利号为99121753.5，发明名称为含有β-胡萝卜素、番茄红素和叶黄素的混合物的类胡萝卜素制剂。此发明与本发明均选用叶黄素作为主要原料。但是本发明添加了竹叶提取物、维生素、氨基酸等原辅料，而此发明更注重竹叶提取物的作用。本发明旨在提供一种预防心脑血管疾病、提高人体免疫力、对恶性肿瘤、青少年性近视、年龄相关性白内障、年龄相关性黄斑变性人群的膳食补充剂。而此发明只是简单的作为食品添加剂、动物饲料、人类食品、药学制剂或化妆品制剂。
(三)发明内容
本发明的目的在于提供一种对视力保健功能、增强免疫力、缓解体力疲劳功能具有显著效果的含有叶黄素微胶囊的功能性饮料。
本发明的目的是这样实现的：由叶黄素微胶囊、竹叶提取物、维生素、氨基酸为主要原料，辅有甜味剂和溶剂，其中维生素为维生素B6、维生素B12；氨基酸为牛磺酸、赖氨酸，甜味剂为葡萄糖、果糖，溶剂为纯净水。各成分的重量以总量1000份计为：叶黄素微胶囊0.1～0.5份、竹叶提取物5～10份、维生素B60.005～0.01份、维生素B120.0005～0.001份、牛磺酸0.1～2份、赖氨酸0.1～0.5份、葡萄糖5～20份、果糖10～25份、纯净水余量。
本发明加入的叶黄素微胶囊是叶黄素晶体经过微囊化工艺制得产品，含量为5％～10％。
本发明加入的竹叶提取物利用国家新资源植物淡竹叶提取浓缩制得。
本发明的有益效果有：
(1)叶黄素：是眼睛视网膜、黄斑不能缺失的主要组成物质；防止眼睛的生理结构和功能变异；是一种强效的抗氧化剂，吸收紫外线、蓝光，根本修复眼睛光损伤；具有血管扩张功能，改善眼底血液微循环，促进营养物质供应。
(2)竹叶提取物：抗自由基，抗氧化，抗衰老；增强免疫力；降低血脂和血胆固醇，保护心脑血管。
(3)维生素B6：属于B族维生素的一种，在体内被磷酸化为辅酶形式，参与酶类代谢，在糖类代谢中催化肌肉与肝中的糖原转化；参与氨基酸代谢，并起重要作用；有助于脑和其它组织中的能量转化过程。
(4)维生素B12：属于B族维生素的一种，在体内转化为各种辅酶参与碳水化合物、脂肪和蛋白质的代谢；促进红细胞的形成；维护神经系统的正常功能。
(5)牛磺酸：属于人体必需氨基酸之一，参与糖代谢的调节，加速糖酵解；能增强心肌收缩力，增加血液输出，同时防止心肌损伤；能保护肝脏。对于维持运动能力牛磺酸是必需的，加强补给可使运动能力和抗运动性疲劳能力进一步增加。
(6)赖氨酸：属于蛋白质的重要组成部分和人体必需氨基酸之一，可以调节人体代谢平衡；能提高钙的吸收以及在体内的积累，加速骨胳生长；有促进生长发育、增加食欲、减少疾病和增强体质的作用。
本发明属于一种含有叶黄素微胶囊的功能性饮料，由叶黄素微胶囊、竹叶提取物、氨基酸及维生素为主要原料，使用现代先进生产工艺，制成的一种预防心脑血管疾病、提高人体免疫力、适用于恶性肿瘤、青少年性近视、年龄相关性白内障、年龄相关性黄斑变性人群。本发明产品各营养成分相互配合，协同作用，能够促进人体新陈代谢，吸收与分解糖分，迅速补充大量的能量物质，具有预防和改善各种眼部不适的疾病，补充人体所需的维生素、氨基酸，补充体力、抗疲劳的卓越功效。
(四)具体实施方式
下面结合具体实施例对本发明作进一步的说明：
实施例1：
本实施例的成分由叶黄素、竹叶提取物、维生素B6、维生素B12、牛磺酸、赖氨酸、葡萄糖、果糖和纯净水组成，其中所述各成分的重量以1000ml计为：叶黄素0.2g、竹叶提取物5.6g、维生素B6 0.007g、维生素B12 0.001g、牛磺酸0.18g、赖氨酸0.3g、葡萄糖8g、果糖12g和纯净水余量，均质、灭菌、灌装。
实施例2：
本实施例的成分与实施例1相同，其中所述各成分的重量以1000ml计为：叶黄素0.4g、竹叶提取物7.5g、维生素B6 0.01g、维生素B12 0.005g、牛磺酸0.15g、赖氨酸0.15g、葡萄糖10g、果糖15g和纯净水余量，均质、灭菌、灌装。
实施例3：
本实施例的成分与实施例1相同，其中所述各成分的重量以1000ml计为：叶黄素0.32g、竹叶提取物6.5g、维生素B6 0.005g、维生素B12 0.001g、牛磺酸0.12g、赖氨酸0.2g、葡萄糖5g、果糖18g和纯净水余量，均质、灭菌、灌装。
实施例4：
本实施例的成分与实施例1相同，其中所述各成分的重量以1000ml计为：叶黄素0.15g、竹叶提取物8.0g、维生素B6 0.008g、维生素B12 0.001g、牛磺酸0.25g、赖氨酸0.2g、葡萄糖11g、果糖16g和纯净水余量，均质、灭菌、灌装。
实施例5：
本实施例的成分与实施例1相同，其中所述各成分的重量以1000ml计为：叶黄素0.3g、竹叶提取物7.5g、维生素B6 0.01g、维生素B12 0.008g、牛磺酸0.17g、赖氨酸0.4g、葡萄糖11g、果糖18g和纯净水余量，均质、灭菌、灌装。
Claims (1)
1.一种含有叶黄素微胶囊的功能性饮料，其特征在于所述各成分的重量以总量1000份计为：叶黄素微胶囊0.1～0.5份、竹叶提取物5～10份、维生素B60.005～0.01份、维生素B120.0005～0.001份、牛磺酸0.1～2份、赖氨酸0.1～0.5份、葡萄糖5～20份、果糖10～25份和纯净水余量，所述的竹叶提取物为利用国家新资源植物淡竹叶提取浓缩制得，所述的叶黄素微胶囊是叶黄素晶体经过微囊化工艺制得产品，含量为5％-10％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101375625A CN101433357B (zh) | 2008-11-19 | 2008-11-19 | 一种含有叶黄素微胶囊的功能性饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101375625A CN101433357B (zh) | 2008-11-19 | 2008-11-19 | 一种含有叶黄素微胶囊的功能性饮料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101433357A CN101433357A (zh) | 2009-05-20 |
| CN101433357B true CN101433357B (zh) | 2011-12-14 |
Family
ID=40708115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101375625A Active CN101433357B (zh) | 2008-11-19 | 2008-11-19 | 一种含有叶黄素微胶囊的功能性饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101433357B (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1917946A (zh) * | 2003-12-18 | 2007-02-21 | Gat制剂有限公司 | 改善生物活性成分的稳定性和贮存期的连续多重微囊包封方法 |
| CN101006817A (zh) * | 2007-01-24 | 2007-08-01 | 邓天华 | 一种竹叶茶及其生产方法 |
| CN101032683A (zh) * | 2006-03-10 | 2007-09-12 | 郑亚津 | 叶黄素微囊及其制备方法 |
-
2008
- 2008-11-19 CN CN2008101375625A patent/CN101433357B/zh active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1917946A (zh) * | 2003-12-18 | 2007-02-21 | Gat制剂有限公司 | 改善生物活性成分的稳定性和贮存期的连续多重微囊包封方法 |
| CN101032683A (zh) * | 2006-03-10 | 2007-09-12 | 郑亚津 | 叶黄素微囊及其制备方法 |
| CN101006817A (zh) * | 2007-01-24 | 2007-08-01 | 邓天华 | 一种竹叶茶及其生产方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101433357A (zh) | 2009-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA06012501A (es) | Composicion nutricional que promueve la perdida de peso, quema calorias, aumenta la termogenesis, sustenta el metabolismo de la energia y/o suprime el apetito. | |
| CN103977157A (zh) | 黑枸杞明目的护眼茶 | |
| CN101766274B (zh) | 含竹叶黄酮的抗氧化功能食品组合物 | |
| CN111436609A (zh) | 含有植物外泌体和白藜芦醇的产品及其制备方法 | |
| KR101578070B1 (ko) | 발모 촉진, 탈모 완화 및 개선, 혈당 조절, 위장 장애 증상 완화 및 개선용 건강보조식품 | |
| JP2023002707A (ja) | キサントフィルとヒシ属植物の加工物を含有する組成物 | |
| CN112602861A (zh) | 一种用于提高免疫力的担子菌复合饮品及其制备方法 | |
| CN106109737A (zh) | 一种抗氧化的营养制剂及其制备方法 | |
| CN1315418C (zh) | 黑木耳燕麦螺旋藻即冲饮品及其制备方法 | |
| CN111528421A (zh) | 含有植物外泌体的护眼产品及其制备方法 | |
| CN105412354A (zh) | 黑枸杞护眼棒棒糖 | |
| CN112869073A (zh) | 提高人体机能和排出有害毒素的中药果蔬组合物及其制备方法 | |
| KR20110119305A (ko) | 타우린, 비타민류, 로얄젤리, 홍삼, 구기자, 글루메이트 (탈지미강, 미베아) 및 애플 에센스를 주성분으로 함유하는 기능성 음료조성물 | |
| CN106174286A (zh) | 高级金枸杞营养果酱 | |
| KR100977849B1 (ko) | 유산균이 함유된 김치를 포함하는 녹즙 조성물 | |
| CN101433357B (zh) | 一种含有叶黄素微胶囊的功能性饮料 | |
| CN109043249A (zh) | 一种蓝莓l-阿拉伯糖复合饮料浓浆 | |
| CN110140950B (zh) | 一种具有抗氧化功能组合物及其制备方法 | |
| KR101010575B1 (ko) | 감식초가 함유된 아토피성 피부질환 개선용 조성물 | |
| CN112691150A (zh) | 一种组合物及其制备方法和应用 | |
| CN102763759A (zh) | 一种黑大蒜口香糖 | |
| CN102308989B (zh) | 一种具有保健功能的红蚁、葡萄、蜂胶提取物的组合物 | |
| KR101849710B1 (ko) | 반려동물 암질환 관리 보조영양제와 그 제조방법 | |
| Khutare et al. | A Review on Various Medicinal Applications of Kiwi Fruit | |
| CN109567154A (zh) | 一种木耳红枣生姜枸杞养生复合营养咀嚼片及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Functional beverage containing xanthophyll microcapsule Effective date of registration: 20120803 Granted publication date: 20111214 Pledgee: Harbin Enterprise Credit Guarantee Center Pledgor: Heilongjiang Jiabao Bio-technology Development Co., Ltd. Registration number: 2012990000425 |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20140704 Granted publication date: 20111214 |
|
| RINS | Preservation of patent right or utility model and its discharge | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Functional beverage containing xanthophyll microcapsule Effective date of registration: 20120803 Granted publication date: 20111214 Pledgee: Harbin Enterprise Credit Guarantee Center Pledgor: Heilongjiang Jiabao Bio-technology Development Co., Ltd. Registration number: 2012990000425 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20150404 Granted publication date: 20111214 |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20150404 Granted publication date: 20111214 |
|
| RINS | Preservation of patent right or utility model and its discharge | ||
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210404 Granted publication date: 20111214 |
|
| PP01 | Preservation of patent right |
Effective date of registration: 20210404 Granted publication date: 20111214 |
|
| PP01 | Preservation of patent right |